RankAlpha logo
Back to Rankings

ACB

Aurora CannabisB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
Re-rating to the analyst high driven by sustained margin expansion, successful international launches, and better-than-expected revenue mix shift toward higher-margin products.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Analyst downgrades or equity raises increasing dilution
Momentum
25
Value
41
Sentiment
100
Setup hits (3d)
— · Net —
AI TargetsBase $6.03 · Bull $10.50 · Bear $4.25
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-26 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net —
Target $4.16
Why
Momentum25 · Δ7d -3.8
Value41 · Δ7d -0.1
Sentiment100 · Δ7d 0.0
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Sentiment · See AI snapshot
Momentum
25
26% active weight
Current posture
7d trendFlat
Δ7d
-3.8
Δ21d
+7.0
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
100
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade B. Momentum 24.8 / Value 41.1 / Sentiment 100.0

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$163.13M
Beta
1.32
Shares Out
61.94M
P/E (TTM) · Derived
-1.7
P/S (TTM)
0.90
P/FCF (TTM) · Derived
-5.65
Rev YoY
+10.0%
EPS YoY
+204.4%
Gross Margin
+4.2%
Op Margin
-17.8%
Net Debt
-$100.92M
Current Ratio
5.94
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology